The CD133 Stem/Progenitor-Like Cell Subset Is Increased in Human Milk and Peripheral Blood of HIV-Positive Women
Frontiers in Cellular and Infection Microbiology, ISSN: 2235-2988, Vol: 10, Page: 546189
2020
- 3Citations
- 23Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations3
- Citation Indexes3
- Captures23
- Readers23
- 23
Article Description
Human milk is a significant source of different CD133 and/or CD34 stem/progenitor-like cell subsets in healthy women but their cell distribution and percentages in this compartment of HIV-positive women have not been explored. To date, a decrease of CD34 hematopoietic stem and progenitor cell frequencies in peripheral blood and bone marrow of HIV-positive patients has been reported. Herein, human milk and peripheral blood samples were collected between day 2–15 post-partum from HIV-positive and HIV-negative women, and cells were stained with stem cell markers and analyzed by flow cytometry. We report that the median percentage of CD45CD34CD133 cell subset from milk and blood was significantly higher in HIV-positive than in HIV-negative women. The percentage of CD45CD34CD133 cell subset from blood was significantly higher in HIV-positive than HIV-negative women. Moreover, percentages of CD45CD34, CD45CD34CD133, and CD45CD34CD133 cell subsets from blood were significantly lower in HIV-positive than HIV-negative women. The CD133 stem/progenitor-like cell subsets are increased in early human milk and blood of HIV-positive women and are differentially distributed to CD34 cell subset frequencies which are decreased in blood.
Bibliographic Details
10.3389/fcimb.2020.546189; 10.3389/fcimb.2020.546189.s001; 10.3389/fcimb.2020.546189.s005; 10.3389/fcimb.2020.546189.s003; 10.3389/fcimb.2020.546189.s002; 10.3389/fcimb.2020.546189.s004
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85092273390&origin=inward; http://dx.doi.org/10.3389/fcimb.2020.546189; http://www.ncbi.nlm.nih.gov/pubmed/33102251; https://www.frontiersin.org/articles/10.3389/fcimb.2020.546189/supplementary-material/10.3389/fcimb.2020.546189.s001; http://dx.doi.org/10.3389/fcimb.2020.546189.s001; https://www.frontiersin.org/articles/10.3389/fcimb.2020.546189/supplementary-material/10.3389/fcimb.2020.546189.s005; http://dx.doi.org/10.3389/fcimb.2020.546189.s005; https://www.frontiersin.org/articles/10.3389/fcimb.2020.546189/supplementary-material/10.3389/fcimb.2020.546189.s003; http://dx.doi.org/10.3389/fcimb.2020.546189.s003; https://www.frontiersin.org/articles/10.3389/fcimb.2020.546189/supplementary-material/10.3389/fcimb.2020.546189.s002; http://dx.doi.org/10.3389/fcimb.2020.546189.s002; https://www.frontiersin.org/articles/10.3389/fcimb.2020.546189/supplementary-material/10.3389/fcimb.2020.546189.s004; http://dx.doi.org/10.3389/fcimb.2020.546189.s004; https://www.frontiersin.org/article/10.3389/fcimb.2020.546189/full; https://dx.doi.org/10.3389/fcimb.2020.546189.s002; https://www.frontiersin.org/articles/10.3389/fcimb.2020.546189/full; https://dx.doi.org/10.3389/fcimb.2020.546189.s003; https://dx.doi.org/10.3389/fcimb.2020.546189.s005; https://dx.doi.org/10.3389/fcimb.2020.546189.s004; https://dx.doi.org/10.3389/fcimb.2020.546189; https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2020.546189/full; https://dx.doi.org/10.3389/fcimb.2020.546189.s001
Frontiers Media SA
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know